Skip to content
Friday, May 27, 2022
Latest:
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
  • PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
  • MindMed Announces Inclusion in FTSE Russell Indexes
Biotech Stock Market News

Biotech Stock Market News

Know First, Act First

  • Cannabis & Cancer
  • General
  • Coronavirus
  • Financing & Fiscal
  • Shareholders

BIOTCHNO

BIOTCHNO Shareholders 

Arbitrator Rules for Neptune Wellness Solutions Inc. in Dispute With Azpa Pharmaceuticals Pty. Ltd.

February 18, 2021April 30, 2021 Bachittar

Canada NewsWire LAVAL, QC, Feb. 18, 2021 /PRNewswire/ – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully

Read more
BIOTCHNO General 

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

February 18, 2021April 30, 2021 Desiree Justice

Canada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology Corp.

Read more
BIOTCHNO Trending 

MindMed’s LSD Neutralizer Study Begins

February 17, 2021April 8, 2021 Bachittar

  Canada NewsWire Potential Emergency Off-Switch for Psychedelic Assisted TherapiesBASEL, Switzerland,Feb. 17, 2021/CNW/ — MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ),

Read more
BIOTCHNO Shareholders 

ESSA Pharma Announces Proposed Public Offering of Common Shares

February 16, 2021April 30, 2021 Bachittar

Canada NewsWire VANCOUVER, BC and HOUSTON, Feb. 16, 2021 /PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on

Read more
BIOTCHNO Financing & Fiscal 

Menarini Silicon Biosystems announces launch of CellMag(TM) product line offering affordable Gold Standard Circulating Tumor Cells capture

February 16, 2021April 30, 2021 Bachittar

  CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from

Read more
BIOTCHNO Cannabis & Cancer 

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

February 16, 2021April 30, 2021 Bachittar

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation Sandusky, Ohio–(Newsfile Corp. – February 16, 2021) – PAO Group, Inc. (OTC

Read more
BIOTCHNO Shareholders 

Mountain Valley MD Holdings to Commence Trading on OTCQB Market Under Ticker MVMDF

February 12, 2021April 30, 2021 Bachittar

  Canada NewsWire TORONTO,Feb. 12, 2021/CNW/ –Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) is pleased

Read more
BIOTCHNO General 

Beyond Medical Announces Appointment of Michael Kelly to its Board of Director and is Working to Close the Final Tranche of Non Brokered Private Placement

February 11, 2021April 30, 2021 Bachittar

Canada NewsWire VANCOUVER, BC,Feb. 11, 2021/CNW/ – Beyond Medical Technologies Inc. (“Beyond Medical” or the “Company“) (CSE: DOCT) (Frankfurt: 7FM3) is

Read more
BIOTCHNO Cannabis & Cancer 

ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 11, 2021April 30, 2021 Bachittar

Canada NewsWire VANCOUVER, BC and HOUSTON, Feb. 11, 2021 /CNW/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused

Read more
BIOTCHNO General 

Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences

February 11, 2021April 8, 2021 Bachittar

Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences Canada NewsWire HYDERABAD, India , Feb. 11, 2021 /CNW/ —

Read more
  • ← Previous
  • Next →

Cannabis

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
BIOTCHNO Cannabis & Cancer 

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan

March 31, 2021July 19, 2021 Raza

TOKYO, Mar 31, 2021 – (JCN Newswire) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co.,

The Valens Company Expands Cannabis 2.0 & 3.0
BIOTCHNO Cannabis & Cancer 

The Valens Company Expands Cannabis 2.0 & 3.0

February 25, 2021April 20, 2021 Bachittar
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
BIOTCHNO Cannabis & Cancer 

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

February 16, 2021April 30, 2021 Bachittar
ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
BIOTCHNO Cannabis & Cancer 

ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 11, 2021April 30, 2021 Bachittar
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057